BearDownAZ's Recent Posts
Title Rating Company Posted on ▲
Re: ESPR Resverlogix Corp. Jun 07, 2016 05:54PM
Re: Managing the message 5 Resverlogix Corp. Jun 08, 2016 09:25AM
Q2 2016 Slide Deck from BIO International 2016 2 BIOASIS TECHNOLOGIES INC Jun 08, 2016 01:19PM
Re: Hide the Ball 3 Resverlogix Corp. Jun 09, 2016 10:48AM
Updates from RH 2 BIOASIS TECHNOLOGIES INC Jun 09, 2016 11:04AM
More sites now recruiting for ZEN003694 NCT02705469 trial 4 Zenith Epigenetics Jun 09, 2016 01:27PM
New content on Publications page of RVX website 4 Resverlogix Corp. Jun 09, 2016 01:37PM
Re: New content on Publications page of RVX website 4 Resverlogix Corp. Jun 09, 2016 02:13PM
Resverlogix Announces Corporate Update Webcast 2 Resverlogix Corp. Jun 09, 2016 02:19PM
Re: More sites now recruiting for ZEN003694 NCT02705469 trial 2 Zenith Epigenetics Jun 09, 2016 02:31PM
Slides from Resverlogix Corporate Update 6/13/16 Resverlogix Corp. Jun 13, 2016 01:29PM
Re: Slides from Resverlogix Corporate Update 6/13/16 4 Resverlogix Corp. Jun 13, 2016 01:41PM
Re: Slides from Resverlogix Corporate Update 6/13/16 3 Resverlogix Corp. Jun 13, 2016 01:51PM
Re: Slides from Resverlogix Corporate Update 6/13/16 3 Resverlogix Corp. Jun 13, 2016 03:54PM
New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains. 2 Zenith Epigenetics Jun 13, 2016 04:27PM
New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains. 4 Resverlogix Corp. Jun 13, 2016 04:30PM
Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains. 2 Resverlogix Corp. Jun 13, 2016 05:10PM
Re: Slides from Resverlogix Corporate Update 6/13/16 4 Resverlogix Corp. Jun 13, 2016 05:36PM
The new competitors: SGLT2 inhibitors and GLP-1 Receptor Agonists 6 Resverlogix Corp. Jun 13, 2016 11:43PM
Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains. 3 Resverlogix Corp. Jun 13, 2016 11:46PM